The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol


Category: Cancer,_functionalintegrativemedicine

Type: Case Study

Author: Burton M. Berkson

Date: 2017

Describes the treatment of a 64-year-old male patient diagnosed with metastatic renal cell carcinoma
(RCC). An integrative program was used developed by one of the authors using intravenous (IV) α-lipoic acid, IV vitamin C, low-dose naltrexone, and hydroxycitrate, and a healthy life style program.

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Not Finding What You're Looking For?

Fill out the form below to let us know.